Enlivex Therapeutics Ltd.
ENLV
←Back to Recent Filings

Filing DATE FP FY End Date URL VIEW
6-K 8/29/2025 Q2 2025 6/30/2025 SEC view
20-F 4/30/2025 Q4 2024 12/31/2024 SEC view
6-K 8/30/2024 Q2 2024 6/30/2024 SEC view
20-F 4/30/2024 Q4 2023 12/31/2023 SEC view
WIREPR 9/11/2023 Q2 2023 6/30/2023 WIRE view data
6-K 9/1/2023 Q2 2023 6/30/2023 SEC view
20-F 4/10/2023 Q4 2022 12/31/2022 SEC view
WIREPR 4/4/2023 Q4 2022 12/31/2022 WIRE view data
WIREPR 12/5/2022 Q3 2022 9/30/2022 WIRE view data
WIREPR 8/22/2022 Q2 2022 6/30/2022 WIRE view data
6-K 8/22/2022 Q2 2022 6/30/2022 SEC view
WIREPR 4/29/2022 Q4 2021 12/31/2021 WIRE view data
20-F 4/29/2022 Q4 2021 12/31/2021 SEC view
WIREPR 11/22/2021 Q3 2021 9/30/2021 WIRE view data
6-K 8/6/2021 Q2 2021 6/30/2021 SEC view
20-F 4/30/2021 Q4 2020 12/31/2020 SEC view
6-K/A 10/13/2020 Q2 2020 6/30/2020 SEC view
20-F 4/30/2020 Q4 2019 12/31/2019 SEC view
20-F/A 1/23/2020 Q4 2018 12/31/2018 SEC view
20-F 4/30/2019 Q4 2018 12/31/2018 SEC view
20-F 4/23/2018 Q4 2017 12/31/2017 SEC view
F-1/A 4/4/2017 Q4 2016 12/31/2016 SEC view
20-F 2/24/2017 Q4 2016 12/31/2016 SEC view
20-F 3/29/2016 Q4 2015 12/31/2015 SEC view
20-F 3/31/2015 Q4 2014 12/31/2014 SEC view